Specialized Medical Company (4019) Fair Value & Analysis
Healthcare · SA · Market cap 3.6B SAR
Fair value as of: Jul 31, 2026
From 26 valuation models · updated today
Share price −15.3% over the past month.
Price vs Fair Value (12 months)
12‑month range 14.19 SAR – 20.80 SAR · fair‑value band 11.98 SAR – 43.88 SAR · the 14.19 SAR price screens below the 16.35 SAR fair value. As of Jul 31, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Specialized Medical Company (4019) currently trades at 14.19 SAR, while our model-based Fair Value estimate is 16.35 SAR, implying the stock looks roughly 15.2% undervalued today. We read business quality at 52/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Specialized Medical Company generated revenue of 1.6B SAR at a net margin of 17.4%. Revenue grew 3.3% year over year. It earns a return on equity of 28.7%. Net debt stands at 286M SAR. Fundamentals as of Jul 31, 2026
Our scenario range runs from 11.98 SAR (bear case) to 43.88 SAR (bull case); at 14.19 SAR, the current price sits within that range. The share trades about 33% below its 52-week high and 1% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -19% fair-value upside, at 15%, 4019 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 31, 2026. TTM = trailing twelve months.
Quality Score breakdown
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Specialized Medical Company owns and operates hospitals, clinics, and medical centers in the Kingdom of Saudi Arabia. The company operates through Medical Services, and Pharmacies and Others segments.
Full company description
Specialized Medical Company owns and operates hospitals, clinics, and medical centers in the Kingdom of Saudi Arabia. The company operates through Medical Services, and Pharmacies and Others segments. It provides diagnostic and therapeutic services for emergency medicine, cardiology, internal and family medicine, and pediatrics; and ancillary services, such as lab histopathology, diagnostic radiology and nuclear medicine, anesthesiology, pharmacy, and physiotherapy rehab. The company also operates surgical units comprising operating room and recovery, delivery unit, ophthalmology, general surgery, obstetrics and gynecology, urology, orthopedics, and ENT; and critical care units, such as neonatal intensive care, CCU, and ICU. In addition, it provides a range of medical and alternative medical services addressing dermatology, anti-aging, and other aesthetic concerns; and home health care, virtual consultation, and dentistry services. Further, the company offers cooked and non-cooked food; hospital and medical facilities maintenance services; and non-medical, healthy food, and food related services, as well as management and operations of restaurants. Specialized Medical Company was incorporated in 1994 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Specialized Medical Company reported revenue of 1.5B SAR in FY2025 versus 280M SAR in FY2021, a compound +53.1%/yr. Reported net income was 266M SAR in FY2025, compounding +105.6%/yr from FY2021.
Is 4019 fairly valued? → Check now
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$100.00 | R$25.67 | -74% |
| Fresenius SE FRE | €39.54 | €31.98 | -19% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.76 SGD | 1.28 SGD | -54% |
| Tenet Healthcare Corporation THC | $178.75 | $300.86 | +68% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.50 | R$46.04 | +42% |
| DaVita Inc DVAI34 | R$1,002 | R$1,038 | +4% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,305 | ₹2,546 | -69% |
| Fresenius Medical Care AG FMSC34 | R$112.00 | R$164.60 | +47% |
| Aier Eye Hospital Group 300015 | ¥8.54 | ¥6.73 | -21% |
Compare Specialized Medical Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Specialized Medical Company (4019) overvalued or undervalued?
What is the fair value of 4019?
What is the quality score of 4019?
What is the revenue of Specialized Medical Company (4019)?
What is the net profit margin of 4019?
Does Specialized Medical Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Specialized Medical Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.